Literature DB >> 12133556

Rehabilitation therapy for short bowel syndrome.

Weiming Zhu1, Ning Li, Jian'an Ren, Jun Gu, Jun Jiang, Jieshou Li.   

Abstract

OBJECTIVE: To investigate the effect of rehabilitation therapy for short bowel syndrome on patient nutritional status and intestinal adaptation.
METHODS: The rehabilitation therapy included enteral or parenteral nutrition, glutamine, recombinant human growth hormone and rehabilitative diet. From January 1997 to July 2000, twenty - seven patients with short bowel syndrome received the treatment. The average age of the patients was 38.5 +/- 19.3 years, and the length of residual small intestine ranged from 15 to 80 cm, with an average of 46.8 +/- 23.4 cm. The ileocecal valve was preserved in 14 cases, and the average time between the onset of short bowel syndrome and the rehabilitation therapy was 86 +/- 105 days.
RESULTS: After the treatment, nutritional status of the patients improved markedly, and intestinal absorptive capacity improved. Eight patients were followed up for more than 2 years, among whom 4 (50%) were weaned from total parenteral nutrition. Thirteen patients were followed up for more than 1 year, and 10 patients (76.9%) were weaned from total parenteral nutrition.
CONCLUSIONS: Rehabilitation therapy for short bowel syndrome can improve patient nutritional status effectively and promote intestinal adaptation, providing a new hope for these patients. The therapeutic effects are related to the length of the residual small intestine, patients age and duration between massive intestinal resection and start of the treatment. Early initiation of rehabilitation therapy promotes intestinal adaptation and increases patients ability to wean from total parenteral nutrition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133556

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

1.  Reconnection surgery in adult post-operative short bowel syndrome < 100 cm: is colonic continuity sufficient to achieve enteral autonomy without autologous gastrointestinal reconstruction? Report from a single center and systematic review of literature.

Authors:  A Lauro; R Cirocchi; N Cautero; A Dazzi; D Pironi; F M Di Matteo; A Santoro; L Pironi; A D Pinna
Journal:  G Chir       Date:  2017 Jul-Aug

Review 2.  The Long Road to the Development of Effective Therapies for the Short Gut Syndrome: A Personal Perspective.

Authors:  Palle Bekker Jeppesen
Journal:  Dig Dis Sci       Date:  2019-10       Impact factor: 3.199

3.  Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial.

Authors:  Theresa A Byrne; Douglas W Wilmore; Kishore Iyer; John Dibaise; Kerri Clancy; Malcolm K Robinson; Peter Chang; Joseph M Gertner; David Lautz
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

4.  Glutamine supplementation in sick children: is it beneficial?

Authors:  Elise Mok; Régis Hankard
Journal:  J Nutr Metab       Date:  2011-11-14

5.  Expression of growth hormone and its receptor in chronic atrophic gastritis and its clinical significance.

Authors:  Jian-Min Si; Qian Cao; Min Gao
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.